Dusseldorf - Delayed Quote EUR

CytomX Therapeutics Inc (6C1.DU)

1.8920
+0.0940
+(5.23%)
At close: May 16 at 7:31:54 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
147,557
138,103
101,214
53,163
37,312
Operating Expense
111,598
113,108
107,698
154,498
153,354
Operating Income
35,959
24,995
-6,484
-101,335
-116,042
Net Non Operating Interest Income Expense
5,897
7,136
9,837
1,678
255
Other Income Expense
-16
-38
-30
340
-83
Pretax Income
41,840
32,093
3,323
-99,317
-115,870
Tax Provision
237
224
3,892
0
0
Net Income Common Stockholders
41,603
31,869
-569
-99,317
-115,870
Diluted NI Available to Com Stockholders
41,603
31,869
-569
-99,317
-115,870
Basic EPS
0.48
0.38
-0.01
-1.51
-1.30
Diluted EPS
0.48
0.38
-0.01
-1.51
-1.30
Basic Average Shares
85,712.3120
84,439.3030
73,808.2370
65,739.8440
64,146.8480
Diluted Average Shares
85,875.2780
84,745.1160
73,808.2370
65,739.8440
64,146.8480
Total Operating Income as Reported
35,959
24,995
-6,484
-101,335
-116,042
Total Expenses
111,598
113,108
107,698
154,498
153,354
Net Income from Continuing & Discontinued Operation
41,603
31,869
-569
-99,317
-115,870
Normalized Income
41,603
31,869
-569
-99,317
-115,870
Interest Income
5,897
7,136
9,837
1,678
255
Net Interest Income
5,897
7,136
9,837
1,678
255
EBIT
35,959
24,995
-6,484
-101,335
-116,042
EBITDA
37,645
26,763
-4,309
-98,892
-113,336
Reconciled Depreciation
1,686
1,768
2,175
2,443
2,706
Net Income from Continuing Operation Net Minority Interest
41,603
31,869
-569
-99,317
-115,870
Normalized EBITDA
37,645
26,763
-4,309
-98,892
-113,336
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 8/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

N04.SG Nucana PLC (ADRs)
0.0320
+3.23%
 
N04.MU Nucana PLC R
0.0475
+6.74%
 
N04.BE Nucana PLC R
0.0825
-2.37%
 
N04.F NuCana plc
0.0390
+30.00%
 
2LB.BE Iovance Biotherapeutics Inc
1.5646
+4.06%
 
NXTC NextCure, Inc.
0.4380
+5.98%
 
ASMB Assembly Biosciences, Inc.
13.42
+7.36%
 
REVB Revelation Biosciences, Inc.
3.0500
-0.97%
 
GLYC GlycoMimetics, Inc.
0.2470
-1.12%
 
GLPG.AS Galapagos NV
24.40
+2.01%